Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689883011 | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689885016 | Codeine phosphate 30 mg and paracetamol 500 mg effervescent powder for oral suspension sachet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689886015 | Acetaminophen 500 mg and codeine phosphate 30 mg effervescent powder for oral suspension sachet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4579811000052119 | kodeinfosfat 30 milligram/dospåse och paracetamol 500 milligram/dospåse, bruspulver till oral suspension | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Co-codamol | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has active ingredient | Non-opioid analgesic (substance) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has active ingredient | Paracetamol | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Acetaminophen + codeine phosphate | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has active ingredient | Morphinan opioid | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has active ingredient | Codeine phosphate | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has active ingredient | Codeine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral powder | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Product containing codeine and paracetamol (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Codeine- and paracetamol-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has manufactured dose form | Effervescent powder for oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has precise active ingredient | Codeine phosphate | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has precise active ingredient | Paracetamol | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | har täljarvärde som visar styrka | 500 | false | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has unit of presentation | Sachet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Paracetamol | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Codeine phosphate | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | har täljarvärde som visar styrka | 30 | false | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Product containing only codeine and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Plays role | Antitussive therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Product containing phenanthrene derivative (product) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR